ProShares Ultra Nasdaq BiotechnologyProShares Ultra Nasdaq BiotechnologyProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology

No trades
See on Supercharts

ProShares Ultra Nasdaq Biotechnology holdings


As of August 22, 2025
Symbol
Weight %
Shares
Market value
U
U.S. Dollar
27.53%
‪‪15.16 M‬‬
‪‪15.16 M‬‬USD
U
US912797QE0United States Treasury Bills 0.0% 09-OCT-2025
9.03%
‪‪5.00 M‬‬
‪‪4.97 M‬‬USD
G
GILDGilead Sciences, Inc.
4.60%
‪‪22.09 K‬‬
‪‪2.54 M‬‬USD
A
AMGNAmgen Inc.
4.50%
‪‪8.44 K‬‬
‪‪2.48 M‬‬USD
R
REGNRegeneron Pharmaceuticals, Inc.
3.96%
‪‪3.70 K‬‬
‪‪2.18 M‬‬USD
V
VRTXVertex Pharmaceuticals Incorporated
3.95%
‪‪5.50 K‬‬
‪‪2.17 M‬‬USD
A
ALNYAlnylam Pharmaceuticals, Inc
3.30%
‪‪3.99 K‬‬
‪‪1.81 M‬‬USD
A
AZNAstraZeneca PLC Sponsored ADR
3.05%
‪‪20.76 K‬‬
‪‪1.68 M‬‬USD
I
INSMInsmed Incorporated
1.53%
‪‪6.40 K‬‬
‪‪844.43 K‬‬USD
A
ARGXargenx SE Sponsored ADR
1.33%
‪‪1.11 K‬‬
‪‪731.28 K‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.